BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7616737)

  • 1. Cancer Chemopreventive Agents: Drug Development Status and Future Prospects. Conference proceedings. Princeton, New Jersey, October 18-22, 1994.
    J Cell Biochem Suppl; 1994; 20():1-303. PubMed ID: 7616737
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer Chemopreventive Agents: Drug Development Status and Future Prospects. Conference proceedings. Princeton, New Jersey, October 18-22, 1994.
    J Cell Biochem Suppl; 1995; 22():1-262. PubMed ID: 8538184
    [No Abstract]   [Full Text] [Related]  

  • 3. Recent results in preclinical and clinical drug development of chemopreventive agents at the National Cancer Institute.
    Kelloff GJ; Boone CW; Malone W; Steele V
    Basic Life Sci; 1993; 61():373-86. PubMed ID: 8304948
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategy and planning for chemopreventive drug development: clinical development plans II.
    Kelloff GJ; Crowell JA; Hawk ET; Steele VE; Lubet RA; Boone CW; Covey JM; Doody LA; Omenn GS; Greenwald P; Hong WK; Parkinson DR; Bagheri D; Baxter GT; Blunden M; Doeltz MK; Eisenhauer KM; Johnson K; Knapp GG; Longfellow DG; Malone WF; Nayfield SG; Seifried HE; Swall LM; Sigman CC
    J Cell Biochem Suppl; 1996; 26():54-71. PubMed ID: 9154168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of cancer chemopreventive agents: oltipraz as a paradigm.
    Kensler TW; Groopman JD; Sutter TR; Curphey TJ; Roebuck BD
    Chem Res Toxicol; 1999 Feb; 12(2):113-26. PubMed ID: 10027787
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer prevention: molecular mechanisms to clinical applications. Proceedings of a conference. New York City, New York, USA. November 10-11, 2000.
    Ann N Y Acad Sci; 2001 Dec; 952():1-183. PubMed ID: 11840999
    [No Abstract]   [Full Text] [Related]  

  • 7. Melatonin in cancer management: progress and promise.
    Jung B; Ahmad N
    Cancer Res; 2006 Oct; 66(20):9789-93. PubMed ID: 17047036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What are the critical attributes for cancer chemopreventive agents?
    Wattenberg LW
    Ann N Y Acad Sci; 1995 Sep; 768():73-81. PubMed ID: 8526387
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives in cancer chemoprevention.
    Stoner GD; Morse MA; Kelloff GJ
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):945-54. PubMed ID: 9255586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer chemopreventive agents in plants - a continuing challenge.
    Gescher A; Gerhäuser C
    Planta Med; 2008 Oct; 74(13):1523-5. PubMed ID: 18843591
    [No Abstract]   [Full Text] [Related]  

  • 11. American Society of Preventive Oncology Distinguished Career Achievement Lecture 2006--Enjoy the journey: the long and winding road of chemoprevention agent development.
    Meyskens FL
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2038-41. PubMed ID: 17119025
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting arachidonic acid pathway by natural products for cancer prevention and therapy.
    Yarla NS; Bishayee A; Sethi G; Reddanna P; Kalle AM; Dhananjaya BL; Dowluru KS; Chintala R; Duddukuri GR
    Semin Cancer Biol; 2016 Oct; 40-41():48-81. PubMed ID: 26853158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical development plan: l-Selenomethionine.
    J Cell Biochem Suppl; 1996; 26():202-18. PubMed ID: 9154178
    [No Abstract]   [Full Text] [Related]  

  • 14. Resveratrol: a review of preclinical studies for human cancer prevention.
    Athar M; Back JH; Tang X; Kim KH; Kopelovich L; Bickers DR; Kim AL
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):274-83. PubMed ID: 17306316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in cancer chemoprevention. Workshop report.
    IARC Sci Publ; 2001; 154():1-12. PubMed ID: 11220649
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical development plan: sulindac sulfone.
    J Cell Biochem Suppl; 1996; 26():227-35. PubMed ID: 9154180
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of cancer chemopreventive agents: a perspective.
    Francy-Guilford J; Pezzuto JM
    Planta Med; 2008 Oct; 74(13):1644-50. PubMed ID: 18537076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronicles in drug discovery.
    Moral MA; Khurdayan VK; Bozzo J
    Drug News Perspect; 2006 Oct; 19(8):485-9. PubMed ID: 17160149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Special issue: Selenium and cancer: Larry C. Clark memorial issue.
    Nutr Cancer; 2001; 40(1):1-77. PubMed ID: 12214566
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical development plan: 13-cis-retinoic acid.
    J Cell Biochem Suppl; 1996; 26():168-201. PubMed ID: 9154177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.